<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>NAFLD Biomarker Discovery Analysis Report</title>
    <style>
        
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            line-height: 1.6;
            margin: 0;
            padding: 20px;
            background-color: #f8f9fa;
        }
        
        .report-container {
            max-width: 1000px;
            margin: 0 auto;
            background-color: white;
            padding: 40px;
            border-radius: 8px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }
        
        .report-header {
            border-bottom: 3px solid #007bff;
            padding-bottom: 20px;
            margin-bottom: 30px;
        }
        
        .report-header h1 {
            color: #2c3e50;
            margin: 0 0 10px 0;
        }
        
        .report-meta p {
            margin: 5px 0;
            color: #6c757d;
        }
        
        h2 {
            color: #2c3e50;
            border-bottom: 2px solid #e9ecef;
            padding-bottom: 10px;
            margin-top: 30px;
        }
        
        h3 {
            color: #495057;
            margin-top: 25px;
        }
        
        .summary-table, .biomarker-table, .pathway-summary, .metadata-table {
            width: 100%;
            border-collapse: collapse;
            margin: 15px 0;
        }
        
        .summary-table td, .biomarker-table td, .biomarker-table th,
        .pathway-summary td, .pathway-summary th, .metadata-table td {
            padding: 10px;
            border: 1px solid #dee2e6;
            text-align: left;
        }
        
        .biomarker-table th, .pathway-summary th {
            background-color: #f8f9fa;
            font-weight: bold;
        }
        
        .executive-summary {
            background-color: #f8f9fa;
            padding: 20px;
            border-radius: 8px;
            margin: 20px 0;
        }
        
        .key-findings, .clinical-significance, .recommendations {
            margin: 15px 0;
        }
        
        ul {
            padding-left: 20px;
        }
        
        li {
            margin: 8px 0;
        }
        
        .report-footer {
            border-top: 2px solid #e9ecef;
            padding-top: 20px;
            margin-top: 40px;
            text-align: center;
            color: #6c757d;
            font-size: 0.9em;
        }
        
        @media print {
            body { background-color: white; }
            .report-container { box-shadow: none; }
        }
    
    </style>
</head>
<body>
    <div class="report-container">
        <header class="report-header">
            <h1>NAFLD Biomarker Discovery Analysis Report</h1>
            <div class="report-meta">
                <p><strong>Project:</strong> NAFLD Metabolomics Study</p>
                <p><strong>Generated by:</strong> Dr. Research Team</p>
                <p><strong>Date:</strong> 2025-06-04</p>
            </div>
        </header>
        
        <main class="report-content">
            
    <div class="executive-summary">
        <h2>Executive Summary</h2>
        
        <div class="key-findings">
            <h3>Key Findings</h3>
            <ul>
                <li>Feature extraction reduced 210 initial features to 56 high-quality features (73.3% reduction)</li><li>Statistical analysis identified 8 significant biomarker candidates (14.3% of tested features)</li><li>Pathway enrichment analysis revealed 12 significantly enriched biological pathways</li>
            </ul>
        </div>
        
        <div class="clinical-significance">
            <h3>Clinical Significance</h3>
            <ul>
                <li>Most significant pathway: Glycolysis / Gluconeogenesis</li>
            </ul>
        </div>
        
        <div class="recommendations">
            <h3>Recommendations</h3>
            <ul>
                <li>Validate identified biomarkers in independent cohorts</li>
                <li>Consider pathway-based therapeutic interventions</li>
                <li>Prioritize top-ranked features for further investigation</li>
            </ul>
        </div>
    </div>
    

    <div class="methodology">
        <h2>Methodology</h2>
        
        <h3>Analysis Pipeline</h3>
        <p>The biomarker discovery analysis was performed using the OmniBio pipeline, which implements state-of-the-art metabolomics data processing and statistical analysis methods.</p>
        
        <h4>Feature Extraction</h4>
        <ul>
            <li><strong>Peak Detection:</strong> OpenMS FeatureFinderMetabo algorithm</li>
            <li><strong>Deduplication:</strong> MS-FLO clustering (m/z tolerance: ±5 ppm, RT tolerance: ±0.1 min)</li>
            <li><strong>Quality Filtering:</strong> Frequency-based and abundance-based filters</li>
            <li><strong>Missing Value Imputation:</strong> Median imputation with group awareness</li>
            <li><strong>Normalization:</strong> Pareto scaling for metabolomics data</li>
        </ul>
        
        <h4>Statistical Analysis</h4>
        <ul>
            <li><strong>Significance Testing:</strong> Welch's t-test with FDR correction</li>
            <li><strong>Effect Size:</strong> Cohen's d calculation</li>
            <li><strong>Multiple Testing Correction:</strong> Benjamini-Hochberg FDR</li>
        </ul>
        
        <h4>Pathway Enrichment</h4>
        <ul>
            <li><strong>Databases:</strong> KEGG Pathways, Gene Ontology</li>
            <li><strong>Enrichment Method:</strong> Fisher's exact test</li>
            <li><strong>Significance Threshold:</strong> p < 0.05 (FDR corrected)</li>
        </ul>
        
        <h4>Quality Control</h4>
        <ul>
            <li><strong>Data Completeness:</strong> Sample and feature coverage assessment</li>
            <li><strong>Outlier Detection:</strong> Robust statistical methods</li>
            <li><strong>Batch Effect Assessment:</strong> Principal component analysis</li>
        </ul>
    </div>
    

    <div class="results">
        <h2>Results Overview</h2>
        
        <div class="data-summary">
            <h3>Data Processing Summary</h3>
            <table class="summary-table">
                <tr><td><strong>Initial Features:</strong></td><td>210</td></tr>
                <tr><td><strong>Final Features:</strong></td><td>56</td></tr>
                <tr><td><strong>Samples Analyzed:</strong></td><td>30</td></tr>
                <tr><td><strong>Feature Reduction:</strong></td><td>73.3%</td></tr>
            </table>
        </div>
        
        <div class="biomarker-candidates">
            <h3>Biomarker Candidates</h3>
            <p><strong>Significant Features Identified:</strong> 8</p>
            
            <h4>Top Biomarker Candidates</h4>
            <table class="biomarker-table">
                <thead>
                    <tr><th>Feature ID</th><th>Statistical Significance</th><th>Effect Size</th></tr>
                </thead>
                <tbody>
    <tr><td>mz_180.0634_rt_120.5</td><td>1.23e-03</td><td>1.45</td></tr><tr><td>mz_146.0579_rt_85.2</td><td>2.46e-03</td><td>1.21</td></tr><tr><td>mz_117.0193_rt_95.8</td><td>3.79e-03</td><td>0.98</td></tr><tr><td>mz_204.0892_rt_105.6</td><td>4.52e-03</td><td>0.87</td></tr><tr><td>mz_166.0528_rt_78.9</td><td>6.23e-03</td><td>0.75</td></tr>
                </tbody>
            </table>
        </div>
    </div>
    

    <div class="statistical-analysis">
        <h2>Statistical Analysis</h2>
        
        <div class="significance-testing">
            <h3>Significance Testing Results</h3>
            <ul>
                <li><strong>Features Tested:</strong> 56</li>
                <li><strong>Significant Features:</strong> 8</li>
                <li><strong>Significance Threshold:</strong> p < 0.05</li>
                <li><strong>Correction Method:</strong> Benjamini-Hochberg FDR</li>
            </ul>
        </div>
        
        <div class="effect-sizes">
            <h3>Effect Size Distribution</h3>
            <p>Effect sizes (Cohen's d) provide a measure of the practical significance of observed differences:</p>
            <ul>
                <li><strong>Small effect (d > 0.2):</strong> Detectable but minimal clinical impact</li>
                <li><strong>Medium effect (d > 0.5):</strong> Moderate clinical relevance</li>
                <li><strong>Large effect (d > 0.8):</strong> Strong clinical significance</li>
            </ul>
        </div>
    </div>
    

    <div class="pathway-analysis">
        <h2>Pathway Enrichment Analysis</h2>
        
        <div class="enrichment-overview">
            <h3>Enrichment Overview</h3>
            <p><strong>Total Significant Pathways:</strong> 12</p>
            
            <table class="pathway-summary">
                <thead>
                    <tr><th>Database</th><th>Significant</th><th>Tested</th><th>Enrichment Rate</th></tr>
                </thead>
                <tbody>
    <tr><td>KEGG</td><td>7</td><td>145</td><td>4.8%</td></tr><tr><td>GO_BP</td><td>3</td><td>89</td><td>3.4%</td></tr><tr><td>GO_MF</td><td>2</td><td>67</td><td>3.0%</td></tr>
                </tbody>
            </table>
        </div>
        
        <div class="top-pathways">
            <h3>Most Significant Pathways</h3>
            <ol>
    <li><strong>Glycolysis / Gluconeogenesis</strong> (p = 1.25e-03)</li><li><strong>Citrate cycle (TCA cycle)</strong> (p = 1.86e-03)</li><li><strong>cellular carbohydrate metabolic process</strong> [BP] (p = 2.35e-03)</li><li><strong>Fatty acid biosynthesis</strong> (p = 3.12e-03)</li><li><strong>glucose metabolic process</strong> [BP] (p = 3.46e-03)</li>
            </ol>
        </div>
    </div>
    

    <div class="quality-control">
        <h2>Quality Control Assessment</h2>
        
        <div class="data-quality">
            <h3>Data Quality Metrics</h3>
            <ul>
                <li><strong>Sample Coverage:</strong> 100% (all samples passed QC)</li>
                <li><strong>Feature Completeness:</strong> High (after imputation)</li>
                <li><strong>Outlier Detection:</strong> No significant outliers identified</li>
                <li><strong>Batch Effects:</strong> Assessed via PCA analysis</li>
            </ul>
        </div>
        
        <div class="processing-steps">
            <h3>Processing Quality</h3>
            <ul>
                <li><strong>Peak Detection:</strong> Successfully applied to all samples</li>
                <li><strong>Feature Alignment:</strong> Cross-sample consistency achieved</li>
                <li><strong>Missing Value Handling:</strong> Robust imputation applied</li>
                <li><strong>Normalization:</strong> Pareto scaling normalized data distribution</li>
            </ul>
        </div>
    </div>
    

    <div class="data-summary">
        <h2>Data Summary</h2>
        
        <div class="analysis-metadata">
            <h3>Analysis Information</h3>
            <table class="metadata-table">
                <tr><td><strong>Project:</strong></td><td>NAFLD Metabolomics Study</td></tr>
                <tr><td><strong>Analysis Date:</strong></td><td>2025-06-04</td></tr>
                <tr><td><strong>Generated:</strong></td><td>2025-06-04 12:38:50</td></tr>
                <tr><td><strong>Pipeline Version:</strong></td><td>OmniBio v1.0</td></tr>
            </table>
        </div>
        
        <div class="file-outputs">
            <h3>Generated Output Files</h3>
            <ul>
                <li><strong>Feature Matrix:</strong> final_feature_matrix.csv</li>
                <li><strong>Significant Features:</strong> significant_features.txt</li>
                <li><strong>Statistical Results:</strong> statistical_analysis.csv</li>
                <li><strong>Pathway Results:</strong> pathway_enrichment.json</li>
                <li><strong>QC Plots:</strong> qc_plots/</li>
            </ul>
        </div>
    </div>
    
        </main>
        
        <footer class="report-footer">
            <p>Generated by OmniBio Biomarker Discovery Pipeline</p>
            <p>Report generated on 2025-06-04</p>
        </footer>
    </div>
</body>
</html>